Clearance-inducing antibodies are responsible for protection against the acute phase of Trypanosoma cruzi infection in mice

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 10, 1997, Pages 1191-1197

  Umekita, L F ^a   Ramos, D P ^a   Mota, I ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Clearance; Complement mediated lysis; Protection; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA; TRYPANOSOMA CRUZI;

PROTOZOON ANTIBODY;

ANIMAL; ARTICLE; IMMUNOLOGY; MOUSE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; MICE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0031242829     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997001000009     Document Type: Article

References (21)

1. Krettli AU & Brener Z (1976). Protective effects of specific antibodies in Trypanosoma cruzi infection. Journal of Immunology, 116: 755-760.
2. McHardy N (1977). Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum. Zeitschrift für Tropenmedizin und Parasitologie, 28: 195-201.
3. Castelo Branco AZCL (1978). Proteção mediada por imunoglobulina G em camundongos infectados com Trypanosoma cruzi. Master's thesis, UFMG, Belo Horizonte, MG, Brazil.
4. Takehara HA & Mota I (1979). Role of different antibody classes in protection against Trypanosoma cruzi infection in mice. Abstracts of the International Congress on Chagas' Disease, Rio de Janeiro, RJ, Brazil, 157.
5. Takehara HA, Perini A & Mota I (1981). Trypanosoma cruzi: role of different antibody classes in protection against infection in the mouse. Experimental Parasitology, 52: 137-146.
6. Brener Z (1969). The behavior of slender and stout forms of Trypanosoma cruzi in the bloodstream of normal and immune mice. Annals of Tropical Medicine and Parasitology, 63: 215-220.
7. Budzko DB, Pizzimenti MC & Kierszenbaum F (1975). Effects of complement depletion in experimental Chagas' disease: immune lysis of virulent bloodforms of Trypanosoma cruzi. Infection and Immunity, 11: 86-91.
8. Krettli AU (1978). Efeito de anticorpos e do complemento sobre tripomastigotas sanguineos de camundongos infectados com Trypanosoma cruzi. Doctoral thesis, Instituto de Ciências Biológicas, UFMG, Belo Horizonte, MG, Brazil.
9. Umekita LF, Takehara HA & Mota I (1988). Role of the antibody Fc in the immune clearance of Trypanosoma cruzi. Immunology Letters, 17: 85-89.
10. Krettli AU & Brener Z (1982). Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. Journal of Immunology, 128: 2009-2012.
11. Umekita LF, Takehara HA & Mota I (1993). Antibody specificity and clearance of Y and CL strains of T. cruzi. Memóries do Instituto Oswaldo Cruz, 88: 199 (Abstract).
12. Umekita LF, Barbaro KC & Mota I (1996). Specificity and role of anti-Trypanosoma cruzi clearance antibodies. Brazilian Journal of Medical and Biological Research, 29: 25-31.
13. Mota I & Umekita LF (1994). Efeito da absorção do soro anti-T. cruzi (cepa Y) com tripomastigotas Y vivos ou fixados sobre o clearance passivo. Annals of the 46th Annual Meeting of the Brazilian Society for Advancement of Science, Florianópolis, SC, Brazil, 781.
14. Krettli AU (1984). Protective antibodies in Trypanosoma cruzi infection: detection, functional activity and possible mechanisms of trypomastigotes killing in vivo and in vitro. Memóries do Instituto Oswaldo Cruz, 79 (Suppl): 59-66.
15. Dalmasso AP & Jarvinen JA (1980). Experimental Chagas' disease in complement-deficient mice and guinea pigs. Infection and Immunity, 28: 434-440.
16. Umezawa ES, Stolf AMS, Colli W & Zingales B (1987). Trypanosoma cruzi antigens recognized by lytic antibodies. Memórias do Instituto Oswaldo Cruz, 82: 135 (Abstract).
17. Chao D & Dusanic DG (1985). Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene, 34: 694-701.
18. Yoshida N (1988). Imunidade contra formas metaciclicas do Trypanosoma cruzi. Identificação de antígenos de superficíe e resistência a infecção aguda. "Livre-docência" thesis, Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, São Paulo, SP, Brazil.
19. Segura EL, Bua J, Camoanini AR, Subias E, Esteva M, Moreno M & Ruiz AM (1986). Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: complement-mediated lytic activity against trypomastigotes and passive immunoprotection in mice. Immunology Letters, 13: 165-171.
20. Mota I & Umekita LF (1989). The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies. Immunology Letters, 21: 223-226.
21. Franquini JR, Pereira-Chiocola VL, Schenkman S & Rodrigues M (1996). Monoclonal antibody 3C9 eliminates T. cruzi trypomastigotes in vivo without mediating lysis in the presence of complement (CoML) or cells (ADCC). Memórias do Instituto Oswaldo Cruz, 91: 253 (Abstract).